The cost-effectiveness of prostate cancer screening using the Stockholm3 test

OBJECTIVES: The European Randomized Study of Screening for Prostate Cancer found that prostate-specific antigen (PSA) screening reduced prostate cancer mortality, however the costs and harms from screening may outweigh any mortality reduction. Compared with screening using the PSA test alone, using...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Andreas A., Hao, Shuang, Jauhiainen, Alexandra, Elfström, K. Miriam, Egevad, Lars, Nordström, Tobias, Heintz, Emelie, Clements, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906342/
https://www.ncbi.nlm.nih.gov/pubmed/33630863
http://dx.doi.org/10.1371/journal.pone.0246674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906342/
https://www.ncbi.nlm.nih.gov/pubmed/33630863
http://dx.doi.org/10.1371/journal.pone.0246674

Ejemplares similares